ALACRITY for Late- and Mid-Life Mood Disorders
ALACRITY 治疗晚年和中年情绪障碍
基本信息
- 批准号:9374695
- 负责人:
- 金额:$ 142万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-22 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdministratorAdultAreaBehavior TherapyBig DataBiometryCaringClinicalCommunitiesCommunity WorkersComplexDataDiseaseEffectivenessElder AbuseElderlyEnsureFundingGrantHealth PolicyHealth Services ResearchHealthcareIncubatorsInterventionIntervention StudiesLeadLearningMedicalMental HealthMethodologyMethodsMissionModelingMonitorMood DisordersMorbidity - disease rateNational Institute of Mental HealthNeurobiologyPersonsPharmacotherapyPoliciesPopulationPovertyPrimary Health CareProcessProductivityQuality ControlResearchResearch PersonnelResearch TrainingSiteStructureTestingWorkanalytical methodbasecareer developmentcommunity interventioncommunity settingcostdesigndisabilityhealth care modelhealth economicsimprovedinnovationmiddle agemobile computingmortalitynovelsocialtherapy developmentuptake
项目摘要
ALACRITY CENTER ABSTRACT
The rapid increase of older persons (73% increase anticipated in US by 2020) and the diseases and
disabilities complicating their care make research in this area a national priority. We focus on late- and mid-life
mood disorders because they are the leading cause of disability, increase medical morbidity and mortality,
cause suffering, and increase the cost of care. Pharmacotherapy addresses the needs of no more than half of
these persons and most non-pharmacological therapies are complex and have limited scalability and reach.
We propose to put into action a novel model of deployment-based behavioral interventions and
implementation, streamlined based on neurobiology models and augmented by mobile technology. Rather
than focusing exclusively on uptake and sustainability of available interventions, many of which are too
complex for community use, we are working to both simplify the treatments themselves and improve their
delivery. Accordingly, our model: 1) Targets groups identified by consumers, community partners, and our
team. 2) Develops its interventions jointly with community partners and a transdisciplinary team and uses
neurobiological concepts as a “simplification rule” for streamlining behavioral interventions so that they can be
used by community clinicians; 3) integrates mobile technology to community interventions at the assessment,
the intervention, and the adherence monitoring levels; and 4) tests its interventions at community sites using
community clinicians to shorten the way to uptake and sustainability. To maximize our impact, we will work
both in settings in which most older and middle-aged people receive care (primary care) and in settings
serving persons with special clinical (elder mistreatment) and social needs (poverty). The Center's approach
is a clear departure from traditional intervention and services research and can lead to a revolutionary change
in how the field thinks about T2 intervention development and deployment in the community.
Our Methods Core will provide quality control for the Center's projects, serve as an incubator for innovative
approaches to novel design and analytic methods that enhance the information yield of effectiveness data. It
also uses big-data to aid the identification of populations in need of novel interventions, provides policy
support, and integrates novel mobile technology approaches to community interventions. The Core will also
evaluate the Center's productivity and impact on the field and disseminate its methodological advances.
We are confident that we can meet the challenges of this work because of our 20 years of working together
with stakeholders and community partners in intervention planning and implementation supported by 4
consecutive NIMH-funded Center grants, a large portfolio of independently funded studies, and a strong
record of research training and career development of junior investigators.
活力中心摘要
老年人的迅速增加(预计到2020年美国将增加73%)以及疾病和
残疾使其护理复杂化,因此这方面的研究成为国家优先事项。我们专注于晚年和中年
情绪障碍,因为它们是残疾的主要原因,增加医疗发病率和死亡率,
造成痛苦,增加医疗费用。药物治疗解决了不超过一半的需求,
这些人和大多数非药物治疗是复杂的,并且具有有限的可扩展性和范围。
我们建议将一种基于部署的行为干预的新模型付诸行动,
实施基于神经生物学模型进行简化并通过移动的技术进行增强。而
而不是仅仅关注现有干预措施的吸收和可持续性,其中许多干预措施也
复杂的社区使用,我们正在努力既简化治疗本身,并提高其
交付.因此,我们的模型:1)目标群体由消费者,社区合作伙伴和我们的
团队2)与社区合作伙伴和跨学科团队共同制定干预措施,
神经生物学概念作为简化行为干预的“简化规则”,
由社区临床医生使用; 3)在评估时将移动的技术集成到社区干预中,
干预措施和依从性监测水平;以及4)使用
社区临床医生,以缩短吸收和可持续性的方式。为了最大限度地发挥我们的影响力,我们将努力
无论是在大多数老年人和中年人接受护理(初级保健)的环境中,
为有特殊临床(虐待老人)和社会需要(贫困)的人提供服务。中心的做法
是对传统干预和服务研究的一个明显的背离,
在该领域如何看待T2干预的发展和部署在社区。
我们的方法核心将为中心的项目提供质量控制,
新的设计和分析方法,提高有效性数据的信息产量的途径。它
还使用大数据来帮助识别需要新干预措施的人群,
支持并将新的移动的技术方法纳入社区干预措施。核心也将
评估该中心的生产力和对该领域的影响,并传播其方法的进步。
我们有信心,由于我们20年的共同努力,我们能够迎接这项工作的挑战
与利益攸关方和社区合作伙伴一起规划和实施干预措施,
连续NIMH资助的中心赠款,独立资助的研究的大组合,以及强大的
初级研究者的研究培训和职业发展记录。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEORGE S ALEXOPOULOS其他文献
GEORGE S ALEXOPOULOS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEORGE S ALEXOPOULOS', 18)}}的其他基金
1/2 Stepped, reward-exposure based therapy vs. PST in late life depression
1/2 阶梯式奖励暴露疗法与 PST 治疗晚年抑郁症的比较
- 批准号:
8613805 - 财政年份:2014
- 资助金额:
$ 142万 - 项目类别:
1/2 Stepped, reward-exposure based therapy vs. PST in late life depression
1/2 阶梯式奖励暴露疗法与 PST 治疗晚年抑郁症的比较
- 批准号:
9251913 - 财政年份:2014
- 资助金额:
$ 142万 - 项目类别:
1/2 Stepped, reward-exposure based therapy vs. PST in late life depression
1/2 阶梯式奖励暴露疗法与 PST 治疗晚年抑郁症的比较
- 批准号:
8842716 - 财政年份:2014
- 资助金额:
$ 142万 - 项目类别:
1/2 Stepped, reward-exposure based therapy vs. PST in late life depression
1/2 阶梯式奖励暴露疗法与 PST 治疗晚年抑郁症的比较
- 批准号:
9036457 - 财政年份:2014
- 资助金额:
$ 142万 - 项目类别:
"Ecosystem Focused Therapy" in Post Stroke Depression
中风后抑郁症的“生态系统聚焦疗法”
- 批准号:
8828785 - 财政年份:2012
- 资助金额:
$ 142万 - 项目类别:
"Ecosystem Focused Therapy" in Post Stroke Depression
中风后抑郁症的“生态系统聚焦疗法”
- 批准号:
8504509 - 财政年份:2012
- 资助金额:
$ 142万 - 项目类别:
"Ecosystem Focused Therapy" in Post Stroke Depression
中风后抑郁症的“生态系统聚焦疗法”
- 批准号:
8644940 - 财政年份:2012
- 资助金额:
$ 142万 - 项目类别:
"Ecosystem Focused Therapy" in Post Stroke Depression
中风后抑郁症的“生态系统聚焦疗法”
- 批准号:
8269430 - 财政年份:2012
- 资助金额:
$ 142万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 142万 - 项目类别:
Fellowship Programs